Jaguars defensive end Josh Hines-Allen said his seven-year-old son, Wesley, is in remission after fighting acute ...

Jacksonville Jaguars DE Josh Hines-Allen gave insight to how he and his family handled his son's cancer diagnosis.

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Jacksonville Jaguars DE Josh Hines-Allen disclosed his son's pediatric cancer diagnosis and the his campaign for ...

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Acute promyelocytic leukemia (APL) is one of the commonest subtypes of acute myeloid leukemia (AML) and has been of particular interest given that it is the first disease for which molecularly ...

Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML). The prognosis of APL is changing, from the worst among AML as it used to be, to currently the best. The ...

Progress in acute promyelocytic leukemia (APL) has reached about an 80 percent cure rate since the disease was first identified in the 1950s. A standard therapy for newly diagnosed patients is the ...

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) that accounts for 10–15% of the approximately 12,330 adults diagnosed with AML in the USA each year. [1] ...

"Remarkable" results with a novel treatment regimen in pediatric acute promyelocytic leukemia (APL) have been reported by researchers at the National Cancer Institute (NCI). Two-year event free ...

Oncotarget Volume 11, Issue 11 reported that relapsed APL, particularly in the high-risk subset of patients, remains an important clinical problem. The probability of relapse is significantly ...